# US 2024/0390437 A1 · Composition for preventing hair loss and promoting hair growth comprising postbiotic components from heat-treat limosilactobacillus fermentum lm1020

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0390437 A1
- Document ID: US20240390437A1
- Status: Published application
- Kind: A1
- Application number: 18/770,789
- Filed: 2024-07-12
- Published: 2024-11-28
- Earliest claimed: 2023-05-23
- Assignees: Lactomason Co., Ltd.
- Applicants: Lactomason Co., Ltd.
- Inventors: Won Young BAE; So Lim SHIN; Woo Hyun JUNG; Tae Rahk KIM
- Web page: https://patentgrep.com/patent/US20240390437A1

## CPC

- A61K 35/747: Lactobacilli, e.g. L. acidophilus or L. brevis
- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A61K 8/34: Alcohols
- A61K 8/365: Hydroxycarboxylic acids; Ketocarboxylic acids
- A61K 8/368: with carboxyl groups directly bound to carbon atoms of aromatic rings
- A61K 8/42: Amides
- A61K 8/49: containing heterocyclic compounds
- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61K 8/67: Vitamins
- A61K 8/81: obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K 8/9789: Magnoliopsida [dicotyledons]
- A61K 8/99: from microorganisms other than algae or fungi, e.g. protozoa or bacteria
- A61K 35/744: Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61P 17/14: for baldness or alopecia
- A61Q 7/00: Preparations for affecting hair growth
- A61K 2800/782: Enzyme inhibitors; Enzyme antagonists
- A61K 2800/85: Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present disclosure relates to heat-treated Limosilactobacillus fermentum LM1020 for preventing hair loss and promoting hair growth, and more particularly, to heat-treated Limosilactobacillus fermentum LM1020 for preventing hair loss and promoting hair growth by promoting the proliferation of dermal papilla cells and a composition containing the same. Heat-treated Limosilactobacillus fermentum LM1020 of the present disclosure and a composition containing the same promotes the proliferation of dermal papilla cells, has excellent 5α-reductase-1 inhibitory activity, and promotes the expression of FGF7, FGF10, and EGF, which are growth factors, and thus have the effect of effect of preventing hair loss and promoting hair growth. The subject cell line referred to as Lactobacillus fermentum LM1020 has the International Depositary Authority accession number KCCM12918P, having been deposited on Dec. 23, 2020.

## Claims

### Claim 1

A cosmetic composition for proliferating dermal papilla cells, comprising:
heat-treated Limosilactobacillus fermentum LM1020 (KCCM12918P) as an active ingredient.

### Claim 2 (depends on 1)

The cosmetic composition for proliferating dermal papilla cells of claim 1,
wherein the heat-treated Limosilactobacillus fermentum LM1020 is derived from fermented dough.

### Claim 3 (depends on 1)

The cosmetic composition for proliferating dermal papilla cells of claim 1,
wherein the heat-treated Limosilactobacillus fermentum LM1020 has a ratio of saturated fatty acids: unsaturated fatty acids: cyclic fatty acids of 0.1 to 2:0.25 to 5:0.03 to 0.6.

### Claim 4 (depends on 1)

The cosmetic composition for proliferating dermal papilla cells of claim 1,
wherein the heat-treated Limosilactobacillus fermentum LM1020 increases the expression of CDK2, CDK4, cyclin B1, and cyclin D1.

### Claim 5 (depends on 1)

The cosmetic composition for proliferating dermal papilla cells of claim 1,
wherein the heat-treated Limosilactobacillus fermentum LM1020 reduces a gene expression level of 5α-reductase-1 and increases gene expression levels of FGF7, FGF10, and EGF.

### Claim 6 (depends on 1)

The cosmetic composition for proliferating dermal papilla cells of claim 1, further comprising:
L-menthol, salicylic acid, and dexpanthenol.

### Claim 7 (depends on 6)

The cosmetic composition for proliferating dermal papilla cells of claim 6,
wherein the heat-treated Limosilactobacillus fermentum LM1020 has a concentration of 1×106 cells/mL or 1×107 cells/mL.

### Claim 8 (depends on 6)

The cosmetic composition for proliferating dermal papilla cells of claim 6, further comprising:
purified water, ethanol, alanine/histidine/lysine polypeptide copper (HCl), polyacrylate crosspolymer-6, coconut acid, proline, tea tree oil, glycerin, peptide, butylene glycol, 1,2-hexanediol, green tea extracts, lavender flower extracts, quince extracts, and ethyl hexanediol.

### Claim 9 (depends on 8)

The cosmetic composition for proliferating dermal papilla cells of claim 8,
wherein the cosmetic composition for proliferating dermal papilla cells increases microbial diversity and lactic acid bacteria diversity of the scalp.

### Claim 10

A food composition for proliferating dermal papilla cells, comprising:
heat-treated Limosilactobacillus fermentum LM1020 (KCCM12918P) as an active ingredient.

### Claim 11 (depends on 10)

The food composition for proliferating dermal papilla cells of claim 10,
wherein the heat-treated Limosilactobacillus fermentum LM1020 is derived from fermented dough.

### Claim 12 (depends on 10)

The food composition for proliferating dermal papilla cells of claim 10,
wherein the heat-treated Limosilactobacillus fermentum LM1020 has a ratio of saturated fatty acids: unsaturated fatty acids: cyclic fatty acids of 0.1 to 2:0.25 to 5:0.03 to 0.6.

### Claim 13

A pharmaceutical composition for treating hair loss, comprising:
heat-treated Limosilactobacillus fermentum LM1020 (KCCM12918P) as an active ingredient.

### Claim 14 (depends on 13)

The pharmaceutical composition for treating hair loss of claim 13,
wherein the heat-treated Limosilactobacillus fermentum LM1020 is derived from fermented dough.

### Claim 15 (depends on 13)

The pharmaceutical composition for treating hair loss of claim 13,
wherein the heat-treated Limosilactobacillus fermentum LM1020 has a ratio of saturated fatty acids: unsaturated fatty acids: cyclic fatty acids of 0.1 to 2:0.25 to 5:0.03 to 0.6.

### Claim 16 (depends on 13)

The pharmaceutical composition for treating hair loss of claim 13,
wherein the heat-treated Limosilactobacillus fermentum LM1020 increases the expression of CDK2, CDK4, cyclin B1, and cyclin D1.

### Claim 17 (depends on 13)

The pharmaceutical composition for treating hair loss of claim 13,
wherein the heat-treated Limosilactobacillus fermentum LM1020 reduces a gene expression level of 5α-reductase-1 and increases gene expression levels of FGF7, FGF10, and EGF.
